Your browser doesn't support javascript.
loading
Identification of Circulating Fibrocytes and Dendritic Derivatives in Corneal Endothelium of Patients With Fuchs' Dystrophy.
De Roo, An-Katrien; Wouters, Jasper; Govaere, Olivier; Foets, Beatrijs; van den Oord, Joost J.
Afiliação
  • De Roo AK; Department of Imaging & Pathology, Laboratory for Translational Cell & Tissue Research, KU Leuven - University of Leuven, Leuven, Belgium 2Department of Pathology, UZ Leuven - University Hospitals Leuven, Leuven, Belgium.
  • Wouters J; Department of Pathology, UZ Leuven - University Hospitals Leuven, Leuven, Belgium.
  • Govaere O; Department of Imaging & Pathology, Laboratory for Translational Cell & Tissue Research, KU Leuven - University of Leuven, Leuven, Belgium 3Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Foets B; Department of Ophthalmology, UZ Leuven - University Hospitals Leuven, Leuven, Belgium 5Department of Neurosciences, Research Group Ophthalmology, KU Leuven - University of Leuven, Leuven, Belgium.
  • van den Oord JJ; Department of Imaging & Pathology, Laboratory for Translational Cell & Tissue Research, KU Leuven - University of Leuven, Leuven, Belgium 2Department of Pathology, UZ Leuven - University Hospitals Leuven, Leuven, Belgium.
Invest Ophthalmol Vis Sci ; 58(1): 670-681, 2017 01 01.
Article em En | MEDLINE | ID: mdl-28135362
Purpose: Fuchs' endothelial corneal dystrophy (FECD) is a degenerative eye disorder affecting 4% of Americans older than 40. It is the leading indication for corneal endothelial (CE) transplantation for which there is a global donor shortage. This study aimed to gain further insight into the pathophysiology of FECD and identify targets for nonsurgical therapy. Methods: CE from patients with late-onset FECD was compared with that of normal controls using microarray expression analysis (n = 4 FECD, n = 4 normal), reverse transcriptase quantitative PCR (n = 9 FECD, n = 8 normal), and immunohistology (n = 55 FECD, n = 15 normal). Results: This led to the identification of circulating fibrocytes and their dendritic derivatives in all examined CE samples with FECD (in all clinical stages of symptomatic FECD and independent of prior cataract surgery). These cells were not present in normal CE. In this study we characterize their morphology, protein expression profile, number, and localization within the CE layer of patients with FECD. Conclusions: Circulating fibrocytes and their dendritic derivatives are a new aspect of FECD that deserves further investigation. Because they are known to cause fibrosis in a variety of organs, they may play a similar role in FECD and might be a valuable target for nonsurgical therapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Endotélio Corneano / Distrofia Endotelial de Fuchs / Estresse Oxidativo Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Invest Ophthalmol Vis Sci Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Endotélio Corneano / Distrofia Endotelial de Fuchs / Estresse Oxidativo Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Invest Ophthalmol Vis Sci Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Estados Unidos